Jazz Pharmaceuticals (JAZZ) Cash from Operations (2010 - 2026)

Jazz Pharmaceuticals has reported Cash from Operations for 17 years, with the latest figure at 408200000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 5.03% year-over-year to 408200000.0; the trailing twelve-month figure through Mar 2026 stood at 1334173000.0 (down 14.39% YoY), and the FY2025 full-year result was 1355773000.0, down 2.88% from the prior year.
• Cash from Operations for Q1 2026 stood at 408200000.0, up from 362518000.0 in the prior quarter.
• The five-year high for Cash from Operations was 474616000.0 in Q3 2025, with the low at 88839000.0 in Q2 2025.
• Average Cash from Operations over 5 years is 324933235.29, with a median of 331352000.0 recorded in 2024.
• Year-over-year, Cash from Operations jumped 626.79% in 2022 and sank 73.19% in 2025.
• Tracing JAZZ's Cash from Operations over 5 years: stood at 341971000.0 in 2022, then slumped by 51.07% to 167339000.0 in 2023, then jumped by 138.19% to 398580000.0 in 2024, then fell by 9.05% to 362518000.0 in 2025, then climbed by 12.6% to 408200000.0 in 2026.
• The last three Cash from Operations figures came in at 408200000.0 (Q1 2026), 362518000.0 (Q4 2025), and 474616000.0 (Q3 2025), per Business Quant data.

Peer Comparison